文章摘要
魏娟娟,张海平,贺文艳,高晓丽,白雪梅,杜 波.感染耐亚胺培南鲍曼不动杆菌临床分布情况及耐药性分析[J].,2017,17(16):3148-3151
感染耐亚胺培南鲍曼不动杆菌临床分布情况及耐药性分析
Clinical Distribution and Resistance of Imipenem-resistant Acinetobacter Baumannii of Patients
投稿时间:2016-08-23  修订日期:2016-09-25
DOI:10.13241/j.cnki.pmb.2017.16.038
中文关键词: 鲍曼不动杆菌  亚胺培南  临床分布  耐药性
英文关键词: Acinetobacer baumannii  Imipenem  Clinical distribution  Drug resistance
基金项目:
作者单位E-mail
魏娟娟 榆林市中医院检验科 陕西 榆林 719000 weijuanjuan_8312@medicine360.net 
张海平 第四军医大学唐都医院神经外科 陕西 西安 710000  
贺文艳 榆林市中医院检验科 陕西 榆林 719000  
高晓丽 榆林市中医院检验科 陕西 榆林 719000  
白雪梅 榆林市中医院检验科 陕西 榆林 719000  
杜 波 榆林市中医院检验科 陕西 榆林 719000  
摘要点击次数: 262
全文下载次数: 89
中文摘要:
      摘要 目的:探讨感染耐亚胺培南(IPM)鲍曼不动杆菌临床分布情况及耐药性。方法:回顾性分析2013~2015年榆林市中医院患者感染鲍曼不动杆菌的临床分布,并对耐亚胺培南鲍曼不动杆菌进行培养、鉴定及药敏试验,分析其耐药情况。结果:2013~2015年我院共分离培养出鲍曼不动杆菌185株,其中IPM耐药99株(53.51 %),IPM敏感86株(46.49 %)。绝大部分菌株分离自痰液标本(138株,74.59 %),其次是血液标本(14株,7.57 %)与尿液标本(12株,6.49 %);来自ICU送检标本菌株数量最多(84株,45.41 %),其次是呼吸内科标本(53株,28.65 %)与神经内科标本(30株,16.22 %)。不同标本类型及科室中IPM耐药及IPM敏感鲍曼不动杆菌占比无显著差异(P>0.05)。IPM耐药鲍曼不动杆菌对抗菌药物耐药性均较高,其中以头孢哌酮/舒巴坦(CSL)敏感性最高(50.51 %);IPM敏感鲍曼不动杆菌对部分抗菌药物耐药性尚可,其中以IPM敏感性最高(93.02 %)。结论:耐亚胺培南鲍曼不动杆菌临床分布广泛,多重耐药性严重甚至出现泛耐药,应当对患者进行药敏试验,以药敏结果选择合适的抗菌药物进行使用。
英文摘要:
      ABSTRACT Objective: To explore the clinical distribution and resistance of imipenem (IPM)-resistant Acinetobacter baumannii of patients. Methods: The clinical distribution of IPM-resistant Acinetobacer baumannii of patients in Traditional Chinese Medicine Hospital of Yulin from 2013 to 2015 was retrospectively analyzed. Results: 185 IPM-resistant Acinetobacer baumannii were isolated cultured, and there were 99 IPM- resistance (53.51 %) and 86 IPM-sensitivity (46.49 %). Most of the strains were isolated from sputum specimen (138, 74.59 %), then the blood specimen (14, 7.57 %) and urine specimen (12, 6.49 %). Most of the strains were sent from ICU (84, 45.41 %), then the respiratory internal department (53, 28.65 %) and neurology department (30, 16.22 %). There were no big difference of the amounts of IPM-resistant and IPM-sensitivity between different specimens and departments (P>0.05). IPM-resistant Acinetobacer baumannii had higher resistance of antibacterial drugs, which had the highest sensitivity of cefoperazone/sulbactam (CSL) (50.51 %). IPM-sensitivity Acinetobacer baumannii had better resistance of antibacterial drugs, which had the highest sensitivity of IPM (93.02 %). Conclusion: IPM-resistant Acinetobacer baumannii widely distribute, which has severe drug resistance or pan-drug resistance, so the clinical doctors should carry on drug resistance test to choose the property antibacterial drugs.
查看全文   查看/发表评论  下载PDF阅读器
关闭